A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
Clinical trial NCT07224672 · RECRUITING
Trial details
- NCT number
- NCT07224672
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-24
- Primary completion
- 2033-01-12
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.